Recruiting
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer
NCT07647263
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +4 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China